SCHEMBL13848523

SCHEMBL13848523

O=C1NC(=O)C(=C/C=N/Nc2ccccc2)C(=O)N1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP1 P53582 2/20 0.49
▸ TAAR1 Q96RJ0 1/20 0.43
▸ NOX1 Q9Y5S8 1/20 0.41
▸ MAPT P10636 9/20 0.39
▸ MEN1 O00255 6/20 0.39
▸ KMT2A Q03164 6/20 0.39
▸ MAPK1 P28482 4/20 0.39
▸ USP2 O75604 2/20 0.39
▸ POLB P06746 2/20 0.39
▸ RECQL P46063 2/20 0.39
▸ GAA P10253 5/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ HPGD P15428 3/20 0.38
▸ ALOX12 P18054 1/20 0.38
▸ MCL1 Q07820 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ HTT P42858 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ NPC1 O15118 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13848138 0.88 METAP1 (0.51) METAP1TAAR1NOX1MAPTMEN1
SCHEMBL13317581 0.72 METAP1 (0.58) METAP1MAPTMEN1KMT2AMAPK1
SCHEMBL16111930 0.72 NOX1 (0.62) TAAR1NOX1MAPTMEN1KMT2A
SCHEMBL16111932 0.72 NOX1 (0.62) TAAR1NOX1MAPTMEN1KMT2A
SCHEMBL13109406 0.72 NOX1 (0.62) TAAR1NOX1MAPTMEN1KMT2A
SCHEMBL27873782 0.70 ALDH1A1 (0.54) METAP1TAAR1MAPTMEN1KMT2A
SCHEMBL13317593 0.70 METAP1 (0.55) METAP1MAPTMEN1KMT2AMAPK1
SCHEMBL14294534 0.69 NOX1 (0.54) TAAR1NOX1MAPTMEN1KMT2A
SCHEMBL2561256 0.69 NOX1 (0.54) TAAR1NOX1MAPTMEN1KMT2A
SCHEMBL2561254 0.69 NOX1 (0.54) TAAR1NOX1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1305026-B1 BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS NOVUSPHARMA SPA (IT) 2009-05-13 — — EP disclosed
US-20080113993-A1 BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS VIA ARIOSTO, 23 (IT) 2008-05-15 — — US disclosed
US-20080113993-A1 BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS VIA ARIOSTO, 23 (IT) 2008-05-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080113993-A1 BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS HIF1A, HIF1AN, PDGFA METAP1 2162/4885TAAR1 3168/4885NOX1 1292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback